Pediatrics Prof. Dr. Leyla Ağaoğlu
✓ Medically verified profileProf. Dr. Leyla Ağaoğlu
✓ Medically verified profile
Quick answer
Prof. Dr. Leyla Ağaoğlu is a pediatric specialist at Acıbadem Fulya Hospital, working in Pediatric Oncology, Pediatric Hematology, and Pediatrics. She treats children with iron deficiency and anemia, leukemia, and lymphoma, drawing on extensive training and academic experience in pediatric hematology and oncology.
About Prof. Dr. Leyla Ağaoğlu
Prof. Dr. Leyla Ağaoğlu is a pediatric specialist working in Pediatric Oncology, Pediatric Hematology, and Pediatrics at Acıbadem Fulya Hospital. Her clinical interests include iron deficiency and anemia in children, leukemia, and lymphoma.
She graduated from İstanbul University Cerrahpaşa Faculty of Medicine and completed her pediatrics training at İstanbul University İstanbul Faculty of Medicine. Her career includes pediatric hematology and oncology fellowships at the University of Chicago, including training in the Pediatric Bone Marrow Transplantation Unit, as well as faculty and department leadership roles at İstanbul University.
International patients can expect pediatric-focused assessment and care for blood disorders and childhood cancers. Prof. Dr. Ağaoğlu provides consultation through Acıbadem Fulya Hospital’s Pediatric Hematology and Pediatric Oncology services.
Areas of Expertise
Conditions treated and procedures performed by this specialist.
Subspecialties
- Pediatric Hematology
- Pediatrics
Education
- 1997İstanbul University İstanbul Faculty of Medicine Pediatric Hematology and Oncology
- 1988İstanbul University İstanbul Faculty of Medicine, Pediatrics / Professor
- 1987Chicago University Pediatric Bone Marrow Transplantation Unit
- 1982İstanbul University İstanbul Faculty of Medicine Pediatrics / Associate Professor
- 1981Chicago University Pediatric Hematology and Oncology / Specialist
- 1977İstanbul University İstanbul Faculty of Medicine Pediatrics
- 1967–1973İstanbul University Cerrahpaşa Faculty of Medicine
Professional Experience
- 2007Acıbadem Healthcare Services
- 1997–2013İstanbul University İstanbul Faculty of Medicine Pediatrics, Department of Hematology / Oncology / Faculty Member
- 1994–1997İstanbul University İstanbul Faculty of Medicine Pediatrics, Department of Hematology and Oncology / Chair
- 1987–1988Chicago University Pediatric Bone Marrow Transplantation Unit / Fellow
- 1985–1993İstanbul University Oncology Institute Department of Pediatric Oncology / Chair
- 1982–1986İstanbul University İstanbul Faculty of Medicine Department of Pediatrics Hematology and Oncology / Chair
- 1979–1981Chicago University Department of Pediatric Hematology and Oncology / Fellow
- 1973–1979İstanbul University İstanbul Faculty of Medicine Department of Pediatrics / Specialist
Professional Memberships
- International Society of Pediatric Oncology (SIOP)
- Children''s Oncology Group (COG)
- Türk Pediatri Kurumu
- American Society of Pediatric Hemotolog, Oncology (ASPHO)
- Türk Tabipler Kurumu
- Milli Pediatri Kurumu
- Turkish Pediatric Oncology Group Association (TPOG)
- Türk Pediatrik Hemotoloji Association (TPHD)
- Türk Hemotolji Association (THD)
- European Hacmetology Association (EHA)
- International Society of Hemotology (ISH)
- American Society of Clinical Oncology (ASCO)
Selected Publications
- Efficacy, Tolerability and Acceptability of Iron Hydroxide Polymaltose Complex Versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients With Iron Deficiency Anaemia. Int J Pediatrics 2011;520-524 Yasa B, Agaoglu L, Unuvar E.
- Respiratory syncytialvirus infection out break among pediatric patients withoncologic diseases and /or bmt Pediatr Pulmonol 2010; 45(3): 307-11 Anak S, Atay D, Unuvar A, Garipardic M, Agaoglu L, Ozturk G, Karakas Z, Devecioglu O.
- How to manage an unresectable or recurrent oblastoma. Pediatr Blood Cancer. 2010; 55(2): 374-6. Saribeyoglu ET, Devecioglu O, Karakas Z, Anak S, Unuvar A, Agaoglu L, Celik A, Gulluoglu M, Bilgic B.
- Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL. Devecioglu O, Yildiz I, Ozbek U. / Dis Markers. 2010 Jan 1;28(6):353-60. Erbilgin Y, Sayitoglu M, Hatirnaz O, Dogru O, Akcay A, Tuysuz G, Celkan T, Aydogan G, Salcioglu Z, Timur C, Yuksel-Soycan L, Ure U, Anak S, Agaoglu L,
- Efficacy and Safety of Deferasirox (Exjade®) in Patients with ß-Thalassemia Major Treated for up to 5 Years. Clark J, Kattamis A. / ASH 51st Annual Meeting and Exposition, Blood 2009. Cappellini MD, Perrotta S, Agaoglu L, Aydinok Y, Capra M, Canatan D, Drelichman G, Kilinc Y, Magnano C, Porter JB, Piga A, Griffel L, Lagrone D,
- Prospective evaluation of patient-reporte dout comes during treatment with defera sirox or defero xamine for iron overload in patients with beta-thalassemia. Cario H, Zoumbos N, Vichinsky E, Opitz H, Ressayre-Djaffer C, Abetz L, Rofail D, Baladi JF. /ClinTher. 2007 May;29(5):909-17. Cappellini MD, Bejaoui M, Agaoglu L, Porter J, Coates T, Jeng M, LaiME,Mangiagli A, Strauss G, Girot R, Watman N, Ferster A, Loggetto S, Abish S,
- Effects of iron deficiency anemia on cognitive function in children. Arzneimittel-Forschung-Drug-Research 2007;57(6A):426-30. Agaoglu L, Torun O, Unuvar E, Sefil Y, Demir D.
- A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. DrelichmanG, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli / Blood. 2006 May 1;107(9):3455-62./Blood. 2006 May 1;107(9):3455-62. Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y,Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S,
- The effect of iron deficiency anemia on the function of theimmune system. Hematol J 5(7): 579-583, 2005 Ekiz C, Agaoglu L, Karakas Z, Gurel N, Yalcin I.
- NAD(P)H: Quinone oxido reductase 1 null genotype is not associated with pediatric de novoa cute leukemia. Pediatr Blood Cancer2004; 43: 568-70. Sirma S, Agaoglu L, Yildiz Y, Cayli D, Horgusluoglu E, Anak S, Yuksel L, Unuvar A, Celkan T, Apak H, Karakas Z, Devecioglu O, Ozbek U.
Frequently Asked Questions
What is Dr. Leyla Ağaoğlu's specialty?
Which hospital does Dr. Leyla Ağaoğlu practise at?
What languages can I use when consulting Dr. Leyla Ağaoğlu?
How can I book an appointment with Dr. Leyla Ağaoğlu?
Is an online video consultation available with Dr. Leyla Ağaoğlu?
How many years of experience does Dr. Leyla Ağaoğlu have?
Can international patients arrange treatment with Dr. Leyla Ağaoğlu?
How do I get a second opinion involving Dr. Leyla Ağaoğlu?
A dedicated team, from first message to follow-up
Our international patient office coordinates your appointment, travel and treatment across the Acıbadem network — including 7 JCI-accredited hospitals — and stays with you in your own language, every step of the way.
Schedule your appointment with Prof. Dr. Leyla Ağaoğlu
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.
Hospitals
Medical Units
Treatments Performed
What patients say about Prof. Dr. Leyla Ağaoğlu
★★★★★From 2,400+ verified patient reviews“My caesarean delivery was handled with real skill and genuine care. Dr. Osmanağaoğlu was calm, precise and deeply reassuring. Everything was clearly explained in my own language.”
“We are deeply grateful for the care our child received for developmental check. Prof. Dr. Ağaoğlu took real time to get our child's diagnosis right.”
“Years of worry ended once I came here for my radiation treatment. Prof. Dr. Ağaoğlu kept me informed and reassured throughout. I have already recommended Acibadem to my family.”
“Thanks to the team here, my anemia treatment could not have gone better. Prof. Dr. Timurağaoğlu treated me as a person, not just a case. I would happily travel here again for any treatment.”